---
figid: PMC2804114__JO2010-257058.001
figlink: /pmc/articles/PMC2804114/figure/fig1/
number: Figure 1
caption: IR and IGF family signaling pathway. Upon the binding of the ligand, the
  activated receptor will undergo autophosphorylation and in turn will phosphorylate
  IRS and SHC. Activated IRS will recruit GRB to the phosphorylated form of SHC adaptor
  protein. The SHC-GRB complex will induce RAS and turn on the MAPK/ERK pathway, inducing
  cell proliferation and survival. Phospho-IRS will also stimulate the PI3 kinase
  to phosphorylate AKT thus initiating its downstream effectors such as mTOR, promoting
  translation, proliferation, and cell survival. Generally, activated AKT will have
  an inhibitory effect on TSC2, allowing Rheb-GDP to be converted to its GTP-bound
  state, thereby activating mTOR and its downstream signaling molecules to promote
  cellular translation. Three different potential targeted therapies are underway
  of investigation in ovarian cancer, including IGF-IR antibodies, IGF-IR kinase inhibitors,
  and AMPK activators such as metformin.
pmcid: PMC2804114
papertitle: Targeting Insulin and Insulin-Like Growth Factor Pathways in Epithelial
  Ovarian Cancer.
reftext: Marie-Claude Beauchamp, et al. J Oncol. 2010;2010:257058.
pmc_ranked_result_index: '30111'
pathway_score: 0.9730972
filename: JO2010-257058.001.jpg
figtitle: IR and IGF family signaling pathway
year: '2010'
organisms: Homo sapiens
ndex: 9b7f591b-dec1-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2804114__JO2010-257058.001.html
  '@type': Dataset
  description: IR and IGF family signaling pathway. Upon the binding of the ligand,
    the activated receptor will undergo autophosphorylation and in turn will phosphorylate
    IRS and SHC. Activated IRS will recruit GRB to the phosphorylated form of SHC
    adaptor protein. The SHC-GRB complex will induce RAS and turn on the MAPK/ERK
    pathway, inducing cell proliferation and survival. Phospho-IRS will also stimulate
    the PI3 kinase to phosphorylate AKT thus initiating its downstream effectors such
    as mTOR, promoting translation, proliferation, and cell survival. Generally, activated
    AKT will have an inhibitory effect on TSC2, allowing Rheb-GDP to be converted
    to its GTP-bound state, thereby activating mTOR and its downstream signaling molecules
    to promote cellular translation. Three different potential targeted therapies
    are underway of investigation in ovarian cancer, including IGF-IR antibodies,
    IGF-IR kinase inhibitors, and AMPK activators such as metformin.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MAPK9
  - MAPK8
  - MAPK11
  - PRKAA1
  - PRKAB1
  - PRKAG2
  - MAPK3
  - PRKAG3
  - MAPK14
  - PRKAB2
  - MAPK10
  - IGF1R
  - PIK3CG
  - IRS4
  - MAPK13
  - PRKAG1
  - TSC2
  - SHC1
  - SHC2
  - STK11
  - PIK3CB
  - SHC3
  - RHEB
  - PIK3R5
  - MAPK1
  - PIK3CD
  - PIK3R6
  - PIK3R4
  - PIK3CA
  - IRS1
  - AKT3
  - IRS2
  - PRKAA2
  - SHC4
  - MTOR
  - AKT1
  - MAPK12
  - PIK3R3
  - NRAS
  - HRAS
  - AKT2
  - KRAS
  - metformin
  - Cancer
genes:
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK9
  entrez: '5601'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK8
  entrez: '5599'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK11
  entrez: '5600'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA1
  entrez: '5562'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB1
  entrez: '5564'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG2
  entrez: '51422'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG3
  entrez: '53632'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK14
  entrez: '1432'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAB2
  entrez: '5565'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK10
  entrez: '5602'
- word: IGF-1R
  symbol: IGF1R
  source: hgnc_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS4
  entrez: '8471'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK13
  entrez: '5603'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAG1
  entrez: '5571'
- word: MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: TSC2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC1
  entrez: '6464'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC2
  entrez: '25759'
- word: LKB1
  symbol: LKB1
  source: hgnc_alias_symbol
  hgnc_symbol: STK11
  entrez: '6794'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC3
  entrez: '53358'
- word: Rheb
  symbol: RHEB
  source: hgnc_symbol
  hgnc_symbol: RHEB
  entrez: '6009'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IGF-IR
  symbol: IGFIR
  source: hgnc_alias_symbol
  hgnc_symbol: IGF1R
  entrez: '3480'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: MAPK/ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS1
  entrez: '3667'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: IRS
  symbol: IRS
  source: bioentities_symbol
  hgnc_symbol: IRS2
  entrez: '8660'
- word: AMPK
  symbol: AMPK
  source: bioentities_symbol
  hgnc_symbol: PRKAA2
  entrez: '5563'
- word: SHC
  symbol: SHC
  source: bioentities_symbol
  hgnc_symbol: SHC4
  entrez: '399694'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: MAPK/ERK
  symbol: MAPK
  source: bioentities_symbol
  hgnc_symbol: MAPK12
  entrez: '6300'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: RAS
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
chemicals:
- word: metformin
  source: MESH
  identifier: D008687
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
